BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1591 related articles for article (PubMed ID: 8426860)

  • 1. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal pathology of the endometrium.
    Deligdisch L
    Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
    Kennedy MM; Baigrie CF; Manek S
    Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of danazol and tamoxifen on endometrial hyperplasia].
    Soh E
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
    Duffy SR; Taylor L
    Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of estrogen on vascular endothelial growth/permeability factor expression by glandular epithelial and stromal cells in the baboon endometrium.
    Niklaus AL; Aberdeen GW; Babischkin JS; Pepe GJ; Albrecht ED
    Biol Reprod; 2003 Jun; 68(6):1997-2004. PubMed ID: 12606344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
    Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
    Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation in the baboon: endometrial responses.
    Fazleabas AT; Kim JJ; Srinivasan S; Donnelly KM; Brudney A; Jaffe RC
    Semin Reprod Endocrinol; 1999; 17(3):257-65. PubMed ID: 10797944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
    Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
    Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endometrium: effects of estrogen and estrogen-progestogen replacement therapy.
    Samsioe G
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():84-92. PubMed ID: 7874191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.